<DOC>
	<DOC>NCT01436825</DOC>
	<brief_summary>OPTIMS is a non interventional validation study of the calculator developed by Bayer for clinician's use in the prophylactic treatment by factor VIII of patients with severe or moderate Haemophilia A with a severe clinical profile. The study takes place during a single visit, at the time of patient enrollment in the study</brief_summary>
	<brief_title>Validation Study of a cOmputer Pharmacokinetic Tool to assIst in the Follow up Care of haeMophilia A Patients</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Patient with severe haemophilia A defined as residual factor VIII activity &lt; 1% or Patient with moderate haemophilia A (residual factor VIII activity &gt;1% and &lt;5%) with severe clinical profile Patient treated in prevention with the same plasma or recombinant factor VIII for at least 6 months Patient whose inclusion visit is performed during a routine visit including a measurement of plasma residual factor VIII :c level In the medical file (retrospective data) the pharmacokinetic parameters are available and have been obtained from a PK analysis of factor VIII level performed with the same anti haemophilic factor than the one used on the inclusion day Patients with haemophilia B</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Haemophilia A</keyword>
	<keyword>Factor VIII</keyword>
	<keyword>Pharmacokinetic</keyword>
	<keyword>Computer Tool validation</keyword>
</DOC>